Cystic fibrosis treatment now available through Diplomat Pharmacy

FLINT, Mich. — As part of a limited panel, Diplomat Pharmacy will offer PARI’s cystic fibrosis treatment Kitabis Pak, a 28-day supply of Tobramycin Inhalation Solution together with a PARI LC Plus nebulizer handset, the specialty pharmacy operator announced Tuesday.

 

Kitabis Pak is an FDA-approved drug-and-device combination for cystic fibrosis, and the first to use nebulized tobramycin, an inhalable antibiotic. 

 

“This unique offering can simplify the process for prescribers and patients facing cystic fibrosis,” said Gary Kadlec, president of Diplomat. “Now, physicians can write a single prescription and be sure their patients are receiving their treatments with the nebulizer handset used during the pivotal clinical trials. We’re excited to be able to offer it, for improved access, adherence and efficacy.”